4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
February 08, 2025 14:30 ET | Source: 4D Molecular Therapeutics, Inc. 3E10…
The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio REN Wearable for Acute and Preventive Treatment of Migraine
BRIDGEWATER, N.J. and NETANYA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Theranica,…
ASSEMBLY ACHIEVES B CORP CERTIFICATION IN APAC
Stagwell (NASDAQ: STGW) Agency Expands Global Commitment to Sustainability HONG KONG, Feb.…
Draup is Now Great Place to Work-Certified
BENGALURU, India, Jan. 30, 2025 /PRNewswire/ -- Draup has been Great Place to…
City of Rio reopens Olympic BMX cycling track to the public and professional athletes
29 January 2025 - The BMX cycling track that hosted competitions at the Olympic…
Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
Readout of ~1K patients at ASCO GI 2025 demonstrates that Signatera™ positive…
Illuccix Receives European Approval
January 16, 2025 17:06 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia…
Santhera Receives Positive NICE Final Guidance for AGAMREE (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Santhera has begun launch preparations for AGAMREE® in UK with first sales…
Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland
AGAMREE® is approved by MHRA for treating Duchenne muscular dystrophy (DMD) in…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…